Medication for Addiction Treatment During COVID-19
As overdose rates rise, we need addiction treatment in hospitals now more than ever. This guidance outlines how to implement medication for addiction treatment (MAT) during predicted COVID-19 surges.
New HHS Practice Guidelines
Here’s the most important takeaway of the “HHS Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder”: All prescribers with a valid state license and DEA can register for an X wavier without mandatory training.
Blueprint for Hospital Opioid Use Disorder Treatment
This comprehensive resource is scalable for any health system, based on our model implemented at diverse sites that demonstrate feasibility at large and small, public and private, urban, and rural hospitals.
Be The Changemaker: Bootcamp For Champions
13 May 2021, 11:00 am
Stigma and Inequity in OUD Care (Session 6)
The current approach to people who use drugs is based on a broken system that creates racial and social injustices. Break the cycle of harm and improve the system of care. Meghan O’Brien, MD, MBE, and Raul Ayala, MD, discuss how to rebuild and reshape hospital culture.
This series offers CME for physicians and self-reported hours for other clinicians.